From the Centers for Medicare & Medicaid Services (CMS) Printer Friendly PDF From CMS: §483.45(g) Labeling of Drugs and Biologicals and §483.45(h) Storage of Drugs and Biologicals: “ensure that all drugs and biologicals used in the facility are labeled in...
Printer Friendly PDF What is Pharmacogenomics (PGx) testing? PGx is rapidly evolving science focused on how an individual’s genes may affect his or her response to medications. While many patients may metabolize a medication appropriately, others may metabolize it too...
Printer Friendly PDF What are GLP-1 Receptor Agonists (GLP-1 RA)? The GLP-1 Receptor Agonist (GLP-1 RA) medications, also referred to as incretin mimetics or GLP-1 analogs, are biochemical variations of naturally occurring GLP-1 altered for enhanced potency and...
Printer Friendly PDF What are Anticholinergic Drugs? Anticholinergic medications (‘anticholinergics’) are drugs that block and inhibit the activity of the neurotransmitter acetylcholine found in the central and peripheral nervous system. In doing so, these drugs...
Printer Friendly PDF What is a Continuous Glucose Monitor (CGM)? A CGM is a wearable device that as the name implies, continually monitors your interstitial blood glucose (sugar) level providing real-time data to inform diabetes management. With expanded access,...
Printer Friendly PDF Common Fall & Winter Respiratory Illnesses Circulating respiratory viruses such as COVID-19, influenza (flu) and respiratory syncytial virus (RSV) aremore common in fall and winter, and can lead to significant illness and disease. COVID-19,...
Printer Friendly PDF Addressing Polypharmacy Polypharmacy, the concurrent use of multiple medications by a single individual, is a common and concerning issue among older adult patients. As we age, the risk for developing chronic health conditions becomes more common,...
Printer Friendly PDF FDA Approves First RSV Vaccines In May 2023, the Food and Drug Administration (FDA) approved the first vaccines for prevention of RSV associated lower respiratory tract disease (LRTD) in adults aged ≥60 years. RSVPreF3 (Arexvy, GSK) is a 1-dose...
Printer Friendly PDF Certain inhalation devices once opened or assembled and in use, must be used within a specified timeframe to avoid reduced stability and sterility, which can impact efficacy of treatment. Medications with shortened expiration dates, as specified...
Printer Friendly PDF About the Beers List The American Geriatric Society (AGS) Beers Criteria® for Potentially Inappropriate Medication (PIM) Use inOlder Adults, commonly called the Beers List, serves as a comprehensive list of medications that older people may want...
Printer Friendly PDF What is Tardive Dyskinesia? [1,2] Tardive Dyskinesia (TD) is an involuntary movement disorder characterized by uncontrollable, abnormal andrepetitive movements of the face, torso and /or other body parts. The physical symptoms of TD often can be...
Printer Friendly PDF The 2023 GOLD Report: Global Strategy for Prevention, Diagnosis, and Management of Chronic Obstructive Lung Disease On an annual basis the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) releases a strategy report covering all...